Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Benitec Biopharma Inc. | d182332dex322.htm |
| EX-32.1 - EX-32.1 - Benitec Biopharma Inc. | d182332dex321.htm |
| EX-31.2 - EX-31.2 - Benitec Biopharma Inc. | d182332dex312.htm |
| EX-31.1 - EX-31.1 - Benitec Biopharma Inc. | d182332dex311.htm |
| EX-21.1 - EX-21.1 - Benitec Biopharma Inc. | d182332dex211.htm |
| EX-4.3 - EX-4.3 - Benitec Biopharma Inc. | d182332dex43.htm |
| 10-K - 10-K - Benitec Biopharma Inc. | d182332d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (No. 333-253258) on Form S-8 and (No. 333-253259) on Form S-3 of Benitec Biopharma Inc. of our report dated September 20, 2021, relating to the consolidated financial statements of Benitec Biopharma Inc., appearing in this Annual Report on Form 10-K of Benitec Biopharma Inc. for the year ended June 30, 2021.
/s/ BAKER TILLY US, LLP
Campbell, CA
September 20, 2021